Please set your featured image
Prosensa wins “Emerging Star Award” at the European Mediscience Awards
Prosensa, the Dutch biopharmaceutical company focusing on rare diseases with a high unmet medical need, has won the Emerging Star accolade at the European Mediscience Awards ceremony held on 21 June.
The European Mediscience Awards is the largest annual gathering of private and publicly quoted healthcare, biotech and life science companies in Europe recognising achievements in the life sciences industry. Supported by Peel Hunt, the inaugural Emerging Star Award celebrates the achievements of a private or young public mediscience company that has demonstrable credibility in terms of business model/strategy, management team and financing. The winner’s focus on innovation is also key, with its technology/IP capable of significant market impact or disruption.
Prosensa established a UK base at Begbroke Science Park two years ago, to take advantage of the Park’s strong links to the research and academic community at the University of Oxford.
Collecting the award, Dr.Giles Campion, Prosensa’s Chief Medical Officer and SVP Research & Development said: “We are very pleased to be recognised by the European Mediscience judging panel. This prestigious award is an additional motivation in our efforts to help patients and their families affected by rare, progressively debilitating diseases.”
The other companies shortlisted for the Mediscience “Emerging Star Award” were BioCartis NV, Sphere Medical Ltd. and former Begbroke Science Park alumni, Oxford Nanopore Technologies Ltd.